Hernández-Martín A, Duat-Rodríguez A
Servicio de Dermatología Hospital Infantil del Niño Jesús. Madrid, España.
Servicio de Neurología, Hospital Infantil del Niño Jesús, Madrid, España.
Actas Dermosifiliogr. 2016 Jul-Aug;107(6):465-73. doi: 10.1016/j.ad.2016.01.009. Epub 2016 Mar 5.
Neurofibromatosis type 1 (NF1) is the most common neurocutaneous syndrome and probably the one best known to dermatologists. Although the genetic locus of NF1 was identified on chromosome 17 in 1987, diagnosis of the disease is still based primarily on clinical observations. The 7 diagnostic criteria of the National Institutes of Health, which were established in 1988, include 3 skin manifestations (café-au-lait spots, freckling on flexural areas, and cutaneous neurofibromas). The age at which these diagnostic lesions appear is variable: onset can be late in some patients while others never develop certain symptoms. Definitive diagnosis may therefore be delayed by years. Although the appearance of the characteristic café-au-lait spots and freckling in the early years of childhood are very suggestive of the disease, these signs are not pathognomonic and, in isolation, do not constitute sufficient evidence to establish a definitive diagnosis. Thus, other diagnoses should be considered in patients whose only symptoms are café-au-lait spots and freckling. By contrast, the presence of multiple cutaneous neurofibromas or at least 1 plexiform neurofibroma is a very specific indication of NF1. Identification of the different types of neurofibroma allows us to confirm the diagnosis and initiate appropriate management.
1型神经纤维瘤病(NF1)是最常见的神经皮肤综合征,可能也是皮肤科医生最为熟知的一种。尽管1987年已确定NF1的基因座位于17号染色体上,但该病的诊断仍主要基于临床观察。1988年制定的美国国立卫生研究院的7项诊断标准包括3种皮肤表现(咖啡斑、屈侧雀斑和皮肤神经纤维瘤)。这些诊断性皮损出现的年龄各不相同:有些患者发病较晚,而另一些患者则从未出现某些症状。因此,明确诊断可能会延迟数年。虽然儿童早期出现特征性的咖啡斑和雀斑很提示该病,但这些体征并非特异性的,仅凭它们并不构成确诊的确凿证据。因此,对于仅有咖啡斑和雀斑症状的患者,应考虑其他诊断。相比之下,多发性皮肤神经纤维瘤或至少1个丛状神经纤维瘤的存在是NF1的非常特异性指征。识别不同类型的神经纤维瘤有助于我们确诊并启动适当的治疗。